	Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study. J Crohns Colitis Shehab M, Azzam N, Al-Hindawi A, Alrashed F, Al-Bawardy B, Abid S, Bashandi AA, AlShihri RM, Mukhtar M, Saadah O, Alharbi O, Al-Darmaki A, Al Harthi S, Al-Ejji K, Ayash A, Al Sahli A, Khamees N, Salem OE, Mohamed EA, Maher M, Daba G, Helal AA, Abdulhakim Alnassar M, Alfadhli A, Quraishi MN, Goodwin SW, Yuan Y, Mosli M, Jairath V. PMID: 42832339 [PubMed - indexed for MEDLINE]
	Post-Operative Ketorolac in Children After Crohn's Ileocecectomy. Pediatr Surg Int Kennedy K, Hwang R, Krumbhaar C, Zhao Y, Penney C, Baxelbaum K, Mitchel E, Grossman A, Mattei P. PMID: 42832108 [PubMed - indexed for MEDLINE]
	Impact of Vedolizumab on Bowel Urgency in Ulcerative Colitis: Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Trials. Gastro Hep Adv Collins AE, Gift T, Kim E, Robinson I. PMID: 42831144 [PubMed]
	ACEBROPHYLLINE REPROGRAMS INFLAMMATORY AND REDOX SIGNALLING IN EXPERIMENTAL ULCERATIVE COLITIS: A DOSE-DEPENDENT STUDY. Georgian Med News Salman O, Al-Zubaidy A. PMID: 42830053 [PubMed - indexed for MEDLINE]
	Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease. Drug Des Devel Ther Zhang Y, Wang N, Zheng W, Liu R, Li L, Zhao X, Zheng X, Han X. PMID: 42829521 [PubMed - indexed for MEDLINE]
	Spatial multi-omics-guided drug development in inflammatory bowel disease: from mucosal immune niches to precision therapy. Front Immunol Wang H, Zhao X, Yang J. PMID: 42828167 [PubMed - indexed for MEDLINE]
	Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis. Front Gastroenterol (Lausanne) Alabdallat MY, Al Ta'ani O, Bakain T, Al-Dwairy A, Ghannam M, Atasi A, Mashal F, Moghib K, Bakheet N, Jagroo JG, Hehr R, Salem A, Cheung D. PMID: 42827438 [PubMed]
	Neutrophil extracellular traps as a potential therapeutic target in inflammatory bowel disease: a systematic review and meta-analysis. Front Immunol Wu YJ, Huang Y, Fang H, Gu BY, Ge HC, Xu RY, Qian JM, Qin DP. PMID: 42824291 [PubMed - indexed for MEDLINE]
	Primary biliary cirrhosis and inflammatory bowel disease: a two-sample bidirectional Mendelian randomization study. Exp Biol Med (Maywood) Yang M, Xie J, Hu J, Wen P, Liu L, Yang Z, Zhang M, Zhu C, Su Y. PMID: 42824239 [PubMed - indexed for MEDLINE]
	Short Crohn's Disease Activity Index Reflects Symptoms but Not Objective Disease Activity in Puerto Rican Patients. Gastro Hep Adv Mendez-Irizarry Y, Cummings-Lopez R, Santiago-Cintron A, Bermudez-Cartagena D, Mendez-Rios J, Torres EA. PMID: 42820049 [PubMed]
	Treatment burden, adaptation, and support needs during exclusive enteral nutrition in children with Crohn's disease: a qualitative meta-synthesis. Front Nutr Wang F, Li X, Guan Y, Tian J, Huang B, Xie J. PMID: 42819977 [PubMed]
	Patient outcomes and healthcare utilisation following implementation of an advanced therapy care pathway for inflammatory bowel disease: a multicentre, prospective quasi-experimental preimplementation/postimplementation study in the Netherlands. BMJ Open Gastroenterol Visser EH, Oude Voshaar MA, Van Linschoten RCA, Hoekstra J, Robbers K, de Jonge V, Koehler E, Verweij KE, van der Wiel S, van der Horst D, van der Woude CJ, van Noord D, West RL, Southwest Netherlands IBD Study Group. PMID: 42823103 [PubMed - indexed for MEDLINE]
	Genome-wide analysis of genetic modifiers of Crohn's disease and ulcerative colitis risk in response to tobacco smoking. EBioMedicine Bai J, Gacesa R, Björk JR, Jansen BH, Faber KN, Weersma RK, Dijkstra G, van der Sloot KWJ, Festen EAM, Initiative on Crohn and Colitis (ICC). PMID: 42822325 [PubMed - as supplied by publisher]
	Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective. Front Microbiol , Benetinová V, Bertková I, Hanzelová Z, Kamlárová A, Kvaková M. PMID: 42819218 [PubMed]
	Wall stiffening is a primary contributor to motility loss in crohn's disease: an electromechanical modeling study. bioRxiv Anantha Krishnan A, Abubaker M, Holland MA. PMID: 42818006 [PubMed]
	Novel side-to-end anastomosis as an alternative in ileocecal Crohn's disease - an observational study. Updates Surg Dziki A, Ostojski K, Mik Z, Braszczy, Mik M. PMID: 42816742 [PubMed - as supplied by publisher]
	Real-world effectiveness and safety of risankizumab induction and maintenance therapy in pediatric patients with Crohn's disease: a multicenter retrospective analysis. J Crohns Colitis Spencer EA, Buck Q, Collen LV, Stein R, Babinski T, Shouval DS, Rinawi F, Russell RK, Zifman E, Topf-Olivestone C, Tzvinikos C, Slae M, Lev-Tzion R, Turner D, Dubinsky MC, Assa A. PMID: 42814795 [PubMed - indexed for MEDLINE]
	External validation of the CATCH Score for predicting clinically significant CT findings in acute Crohn's disease. Rev Esp Enferm Dig Özkan ÖF, Cindoruk M, Karata, Albayrak HC, Karakan T, Kekilli M. PMID: 42813907 [PubMed - as supplied by publisher]
	Metabolic reprogramming in ulcerative colitis: integrating dietary drivers, pathogenesis, and therapeutic advances. Front Immunol Liu Y, Wan Y, Lu X, Xu A, Ding X, Li Y. PMID: 42813042 [PubMed - indexed for MEDLINE]
	TGM2 Activates the ERK Signaling Pathway to Disrupt Intestinal Barrier Function and Aggravate Colitis. Front Biosci (Landmark Ed) Dai H, Dai L, Xu Y, Liu X. PMID: 42811980 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 59010

Page 1 of 2951



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy